ConductScience.org, home

Paper26558795

Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis.

Mohamad B and 8 others. Hepatol Int, 2016. Cited by 134 papers, by iCite.

Cite this record

ConductScience Library. Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis. Papers, record 26558795. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26558795

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis.
PubMed
Journal
Hepatol Int
PubMed
Year
2016
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
134
iCite
Relative citation ratio, by iCite
4.54
iCite
Revised in PubMed
2022-04-09
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mohamad BBashar
2Shah VVaishal
3Onyshchenko MMykola
4Elshamy MMohammed
5Aucejo FFederico
6Lopez RRocio
7Hanouneh IAIbrahim A
8Alhaddad RRazan
9Alkhouri NNaim

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, HepatocellularMajor topic
Liver CirrhosisMajor topic
Liver NeoplasmsMajor topic
Non-alcoholic Fatty Liver DiseaseMajor topic
Aged
Female
Humans
Male
Middle Aged
Neoplasm Recurrence, Local
Prognosis
Retrospective Studies
Risk Factors
Survival Analysis

Source PubMed

Download CSV of topics

References34

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121374666Management of hepatocellular carcinoma: an update.Hepatology2011https://conductscience.org/library/papers/21374666PubMed
216256907Resection of hepatocellular carcinoma in noncirrhotic liver: analysis of risk factors for survival.J Am Coll Surg2005https://conductscience.org/library/papers/16256907PubMed
322251466Clinical features of nonalcoholic fatty liver disease-associated hepatocellular carcinoma.Hepatobiliary Pancreat Dis Int2012https://conductscience.org/library/papers/22251466PubMed
423041539Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review.Clin Gastroenterol Hepatol2012https://conductscience.org/library/papers/23041539PubMed
517617329Survival and recurrence rates after resection for hepatocellular carcinoma in noncirrhotic livers.J Am Coll Surg2007https://conductscience.org/library/papers/17617329PubMed
621898753Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis.Diabetes Metab Res Rev2012https://conductscience.org/library/papers/21898753PubMed
720666689Population-based risk factors and resource utilization for HCC: US perspective.Curr Med Res Opin2010https://conductscience.org/library/papers/20666689PubMed
819224838Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.J Clin Oncol2009https://conductscience.org/library/papers/19224838PubMed
924990270Characterization and prognosis of patients with hepatocellular carcinoma (HCC) in the non-cirrhotic liver.BMC Gastroenterol2014https://conductscience.org/library/papers/24990270PubMed
1020209604The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis.Hepatology2010https://conductscience.org/library/papers/20209604PubMed
1115915461Design and validation of a histological scoring system for nonalcoholic fatty liver disease.Hepatology2005https://conductscience.org/library/papers/15915461PubMed
1221128245Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis.Int J Cancer2011https://conductscience.org/library/papers/21128245PubMed
132819932Diabetes mellitus and primary hepatocellular carcinoma.Q J Med1986https://conductscience.org/library/papers/2819932PubMed
1412419825The major lipid peroxidation product, trans-4-hydroxy-2-nonenal, preferentially forms DNA adducts at codon 249 of human p53 gene, a unique mutational hotspot in hepatocellular carcinoma.Carcinogenesis2002https://conductscience.org/library/papers/12419825PubMed
1525632192Characteristics of hepatocellular carcinoma in cirrhotic and non-cirrhotic non-alcoholic fatty liver disease.World J Gastroenterol2015https://conductscience.org/library/papers/25632192PubMed
1620432259Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection.Hepatology2010https://conductscience.org/library/papers/20432259PubMed
1716006003Prevalence of and risk factors for fatty liver in a general population of Shanghai, China.J Hepatol2005https://conductscience.org/library/papers/16006003PubMed
1819818310NASH and HCC.Clin Liver Dis2009https://conductscience.org/library/papers/19818310PubMed
1921306970Hepatocellular cancer in the non-cirrhotic liver.J Visc Surg2011https://conductscience.org/library/papers/21306970PubMed
2023302015Non-alcoholic fatty liver disease contributes to hepatocarcinogenesis in non-cirrhotic liver: a clinical and pathological study.J Gastroenterol Hepatol2013https://conductscience.org/library/papers/23302015PubMed

See all 34 referencesDownload CSV of references

Cited by91

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 134 citations.

PMIDTitleJournalYearIn PapersSource
42450325Integrated Plasma and Tissue Lipid Profiling Demonstrates a Distinctive Metabolic Profile in MAFLD-Associated Non-Cirrhotic Hepatocellular Carcinoma.Int J Mol Sci2026https://conductscience.org/library/papers/42450325PubMed
42305340Assessing hepatosteatosis in endogenous Cushing's syndrome: the hepatic steatosis index as a reliable diagnostic tool.Arch Med Sci2026https://conductscience.org/library/papers/42305340PubMed
42274972Global trends in metabolic-associated hepatocellular carcinoma: genetic and socio-demographic drivers.Hepatol Int2026https://conductscience.org/library/papers/42274972PubMed
42162172Bioinformatics and experimental validation of druggable targets in non-alcoholic fatty liver disease.Sci Rep2026https://conductscience.org/library/papers/42162172PubMed
41607858The Emerging Challenge of Non-Cirrhotic MASLD-Related Hepatocellular Carcinoma: Etiology, Immunopathology, and Precision Oncology.Liver Cancer2026https://conductscience.org/library/papers/41607858PubMed
41546486Progression to Decompensation of Severe Fibrosis Compared to Cirrhosis in MASLD: A Systematic Review and Meta-Analysis.Liver Int2026https://conductscience.org/library/papers/41546486PubMed
41476776Signalling pathways in hepatocellular carcinoma (HCC) metastasis and invasion: Molecular mechanisms and therapeutic implications.Biochem Biophys Rep2026https://conductscience.org/library/papers/41476776PubMed
41439075Intracardiac Mass Reveals Hepatocellular Carcinoma: A Rare Case of Cardiac Metastasis.Cureus2025https://conductscience.org/library/papers/41439075PubMed
41097767Association of TP53 with Defective Long Chain 3-Hydroxy acyl-CoA Dehydrogenase Induced Non-Cirrhotic Hepatocellular Carcinoma.Cancers (Basel)2025https://conductscience.org/library/papers/41097767PubMed
41079925Immunotherapy resistance in MASLD-related hepatocellular carcinoma: special immune microenvironment and gut microbiota.Int J Biol Sci2025https://conductscience.org/library/papers/41079925PubMed
40869967Genomic Alterations and Microbiota Crosstalk in Hepatic Cancers: The Gut-Liver Axis in Tumorigenesis and Therapy.Genes (Basel)2025https://conductscience.org/library/papers/40869967PubMed
40704067Myeloid TGF-β signaling shapes liver macrophage heterogeneity and metabolic liver disease pathogenesis.JHEP Rep2025https://conductscience.org/library/papers/40704067PubMed
40385594Characterisation of non-cirrhotic MAFLD-related hepatocellular carcinoma: a retrospective cohort study.Ther Adv Chronic Dis2025https://conductscience.org/library/papers/40385594PubMed
40200415Characterization of non-alcoholic fatty liver disease-related hepatocellular carcinoma on contrast-enhanced ultrasound with Sonazoid.Ultrasonography2025https://conductscience.org/library/papers/40200415PubMed
40103882
HEPNET Position Statement-I, Case Definition, Classification, Screening & Diagnosis of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Pakistan: A Resource for Primary and Secondary Care Physicians.
Pak J Med Sci2025https://conductscience.org/library/papers/40103882PubMed
40041922Drug discovery targeting thyroid hormone receptor β (THRβ) for the treatment of liver diseases and other medical indications.Acta Pharm Sin B2025https://conductscience.org/library/papers/40041922PubMed
39500609
Risk-stratified hepatocellular carcinoma screening according to the degree of obesity and progression to cirrhosis for diabetic patients with metabolic dysfunction-associated steatotic liver disease (MASLD) in Japan: a cost-effectiveness study.
BMJ Open2024https://conductscience.org/library/papers/39500609PubMed
39337628Biomarker Discovery in Liver Disease Using Untargeted Metabolomics in Plasma and Saliva.Int J Mol Sci2024https://conductscience.org/library/papers/39337628PubMed
38911205What should be the best approach post-liver resection in non-viral non-cirrhotic hepatocellular carcinoma?Hepatobiliary Surg Nutr2024https://conductscience.org/library/papers/38911205PubMed
38852583EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).Obes Facts2024https://conductscience.org/library/papers/38852583PubMed

See all 91 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/26558795

GET https://conductscience.org/api/papers/v1/26558795/references?page=2